Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort.

Simuni T, Merchant K, Brumm MC, Cho H, Caspell-Garcia C, Coffey CS, Chahine LM, Alcalay RN, Nudelman K, Foroud T, Mollenhauer B, Siderowf A, Tanner C, Iwaki H, Sherer T, Marek K, Parkinson’s Progression Marker Initiative Authors

Open source

DOI
10.1038/s41531-022-00404-w
Published
2022 Oct 22
Container
NPJ Parkinson's disease
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41531-022-00404-w,
  title = {Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort.},
  author = {Simuni T and Merchant K and Brumm MC and Cho H and Caspell-Garcia C and Coffey CS and Chahine LM and Alcalay RN and Nudelman K and Foroud T and Mollenhauer B and Siderowf A and Tanner C and Iwaki H and Sherer T and Marek K and Parkinson’s Progression Marker Initiative Authors},
  year = {2022},
  journal = {NPJ Parkinson's disease},
  doi = {10.1038/s41531-022-00404-w},
  url = {https://doi.org/10.1038/s41531-022-00404-w}
}

RIS

TY  - JOUR
TI  - Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort.
AU  - Simuni T
AU  - Merchant K
AU  - Brumm MC
AU  - Cho H
AU  - Caspell-Garcia C
AU  - Coffey CS
AU  - Chahine LM
AU  - Alcalay RN
AU  - Nudelman K
AU  - Foroud T
AU  - Mollenhauer B
AU  - Siderowf A
AU  - Tanner C
AU  - Iwaki H
AU  - Sherer T
AU  - Marek K
AU  - Parkinson’s Progression Marker Initiative Authors
PY  - 2022
JO  - NPJ Parkinson's disease
DO  - 10.1038/s41531-022-00404-w
UR  - https://doi.org/10.1038/s41531-022-00404-w
ER  - 

APA

T, S., K, M., MC, B., H, C., C, C., CS, C., LM, C., RN, A., K, N., T, F., B, M., A, S., C, T., H, I., T, S., K, M., & Authors, P. P. M. I. (2022). Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort.. NPJ Parkinson's disease. https://doi.org/10.1038/s41531-022-00404-w

Source records